DAYU BIOLOGICAL
871970
WuHan Hvsen Biotechnology
300871
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
4
Jiangsu LiXing General Steel Ball
300421
5
Guangdong Kitech New Material Holding
300995
US Stock MarketDetailed Quotes
ACN Accenture
- 308.900
- +1.720+0.56%
Close Mar 25 16:00 ET
- 308.701
- -0.199-0.06%
Post 20:01 ET
209.55BMarket Cap25.47P/E (TTM)
312.470High305.420Low3.89MVolume307.550Open307.180Pre Close1.20BTurnover0.62%Turnover Ratio27.00P/E (Static)678.37MShares398.35052wk High7.17P/B192.67BFloat Cap275.17352wk Low5.54Dividend TTM623.73MShs Float398.350Historical High1.79%Div YieldTTM2.30%Amplitude7.942Historical Low309.089Avg Price1Lot Size
Accenture Key Stats
Quarterly+Annual
YOY
| (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 35.81%2.85B | 105.09%1.02B | -4.13%9.13B | -0.59%3.39B | -4.48%3.14B | -9.83%2.1B | 0.64%498.55M | -0.18%9.52B | -10.05%3.41B | 7.33%3.29B |
| Net income from continuing operations | 6.63%1.82B | 15.23%2.32B | 5.94%7.42B | 22.05%1.72B | -3.27%1.98B | 10.22%1.71B | 0.69%2.01B | 0.21%7B | -16.79%1.41B | 12.59%2.05B |
| Depreciation and amortization | 5.07%365.1M | 10.27%378.64M | 2.09%1.43B | 4.80%393.76M | -3.61%345.43M | 1.27%347.49M | 6.12%343.37M | 6.87%1.4B | 10.64%375.74M | 9.07%358.35M |
| Deferred tax | 1,473.05%134.13M | 343.00%59.22M | 65.05%-93.99M | -29.40%-171.73M | 354.62%111.88M | 74.13%-9.77M | 55.31%-24.37M | -26.09%-268.95M | 28.46%-132.72M | -262.74%-43.94M |
| Other non cash items | 1,584.30%127.15M | -7.59%170.8M | -10.31%593.08M | 2.37%281.93M | 373.02%118.77M | -97.42%7.55M | 35.18%184.83M | 13.71%661.25M | 177.35%275.39M | -121.11%-43.5M |
| Change In working capital | 52.71%-281.54M | 2.68%-2.37B | -82.13%-2.16B | -30.53%764.02M | -77.76%110.64M | -32.16%-595.3M | -4.55%-2.44B | -46.96%-1.19B | -25.90%1.1B | 57.65%497.44M |
| -Change in receivables | 60.41%303.01M | -46.50%-1.23B | -786.60%-601.94M | -102.96%-14.72M | 216.30%60.12M | -24.72%188.9M | -37.21%-836.23M | 103.64%87.67M | 172.32%497.88M | 93.49%-51.7M |
| -Change in payables and accrued expense | 61.54%-778.52M | -172.25%-380.87M | -41.99%-454.18M | 17.94%1.1B | -15.57%613.44M | -81.16%-2.02B | 83.71%-139.89M | -115.09%-319.88M | -17.54%929.59M | -45.12%726.57M |
| -Change in other current assets | -1,534.52%-445.91M | 32.97%-441.51M | -62.14%-853.2M | -35.11%40.71M | -396.13%-266.35M | 113.67%31.08M | -113.87%-658.65M | 26.60%-526.23M | 2,013.67%62.73M | 47.85%-53.69M |
| -Change in other current liabilities | -144.93%-119.31M | 95.94%-11.91M | 52.62%-277.97M | 56.36%-73.81M | -106.42%-176.61M | 664.48%265.53M | -2.84%-293.09M | -31.53%-586.74M | -248.16%-169.14M | 32.15%-85.56M |
| -Change in other working capital | -19.51%759.19M | 38.60%-313.4M | -82.23%28.4M | -28.55%-284.48M | -214.12%-119.97M | 36.64%943.24M | -88.34%-510.39M | -75.36%159.82M | -451.22%-221.3M | -355.65%-38.19M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 35.81%2.85B | 105.09%1.02B | -4.13%9.13B | -0.59%3.39B | -4.48%3.14B | -9.83%2.1B | 0.64%498.55M | -0.18%9.52B | -10.05%3.41B | 7.33%3.29B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 81.56%-407.28M | 54.93%-385.52M | -169.28%-7.06B | -13.17%-1.55B | -49,207.71%-2.45B | -361.69%-2.21B | -9.38%-855.43M | 38.45%-2.62B | 2.95%-1.37B | 100.75%4.99M |
| Net PPE purchase and sale | -55.53%-170.81M | -120.80%-152.21M | 2.21%-516.51M | -18.49%-213.64M | 12.28%-124.12M | -2.12%-109.82M | 30.25%-68.93M | 26.44%-528.17M | -1.83%-180.29M | 27.29%-141.5M |
| Net business purchase and sale | 88.54%-240.63M | 70.01%-236.29M | -211.13%-6.55B | -12.19%-1.34B | -1,726.68%-2.33B | -462.78%-2.1B | -14.90%-788.03M | 40.75%-2.11B | 3.58%-1.19B | 130.13%143.22M |
| Net other investing changes | 95.76%4.16M | 94.44%2.97M | -28.79%8.67M | -42.74%2.17M | -12.89%2.85M | -14.97%2.13M | -41.68%1.53M | -3.20%12.18M | 18.94%3.79M | 11.48%3.27M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 81.56%-407.28M | 54.93%-385.52M | -169.28%-7.06B | -13.17%-1.55B | -49,207.71%-2.45B | -361.69%-2.21B | -9.38%-855.43M | 38.45%-2.62B | 2.95%-1.37B | 100.75%4.99M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -18.19%-2.21B | 277.31%2.75B | -7.41%-6.06B | -64.08%-2.43B | 77.70%-216.9M | -23.12%-1.87B | 7.45%-1.55B | -6.29%-5.65B | -34.40%-1.48B | 11.84%-972.82M |
| Net issuance payments of debt | --0 | --4.13B | 727.79%827.79M | -771.25%-671.25M | 367,310.05%1.5B | --0 | --0 | --100M | 767.30%100M | 115.38%408K |
| Net common stock issuance | -19.40%-1.24B | 41.03%-420.9M | -9.80%-3.11B | 43.68%-477.62M | -248.81%-878.73M | -33.52%-1.04B | 25.11%-713.69M | -2.24%-2.83B | -85.88%-848.12M | 46.87%-251.92M |
| Cash dividends paid | -14.33%-928.99M | -14.26%-925.56M | -14.65%-3.24B | -14.42%-807.87M | -14.59%-810.98M | -14.77%-812.58M | -14.81%-810.06M | -15.06%-2.83B | -15.04%-706.06M | -15.31%-707.74M |
| Net other financing activities | -130.71%-38.51M | -10.06%-31M | -513.22%-543.3M | -1,708.07%-472.21M | -93.35%-26.24M | 48.21%-16.69M | -68.77%-28.16M | -2.54%-88.6M | 39.18%-26.12M | -5.97%-13.57M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -18.19%-2.21B | 277.31%2.75B | -7.41%-6.06B | -64.08%-2.43B | 77.70%-216.9M | -23.12%-1.87B | 7.45%-1.55B | -6.29%-5.65B | -34.40%-1.48B | 11.84%-972.82M |
| Net cash flow | ||||||||||
| Beginning cash position | 16.32%8.31B | -44.67%5B | 14.64%9.05B | -35.13%5.54B | -17.92%5.12B | 21.04%7.14B | 14.64%9.05B | -3.41%7.89B | 27.33%8.54B | 14.14%6.24B |
| Current changes in cash | 112.22%241.09M | 277.53%3.39B | -417.90%-3.99B | -204.39%-586.69M | -79.58%474.13M | -686.36%-1.97B | 2.79%-1.91B | 4,216.07%1.26B | -56.10%562M | 79.37%2.32B |
| Effect of exchange rate changes | -21.20%-56.71M | -1,993.59%-87.12M | 54.32%-46.26M | 202.93%53.95M | -133.22%-58.02M | -1,891.96%-46.79M | 117.30%4.6M | 59.13%-101.27M | 44.15%-52.41M | 56.21%-24.88M |
| End cash Position | 65.79%8.49B | 16.32%8.31B | -44.67%5B | -44.67%5B | -35.13%5.54B | -17.92%5.12B | 21.04%7.14B | 14.64%9.05B | 14.64%9.05B | 27.33%8.54B |
| Free cash flow | 34.72%2.68B | 102.57%870.28M | -4.24%8.61B | -1.65%3.18B | -4.13%3.02B | -10.41%1.99B | 8.33%429.62M | 1.96%9B | -10.63%3.23B | 9.68%3.15B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings